Just published @NEJM
A striking 90% reduction in death for booster shots (vs not receiving the 3rd shot) among over 840,000 people, age 50 or older
https://t.co/W22vriA1Se
🗞️@CRISPRTX announced that the FDA granted Regenerative Medicine Advanced Therapy designation to CTX110™, its wholly-owned allogeneic CAR-T cell therapy targeting CD19+ B-cell malignancies.
https://t.co/WmFnAeEIJf
“Mask-wearing is the single most effective public health measure at tackling Covid, reducing incidence by 53%, the first global study of its kind shows.”
https://t.co/5azhr6Z6LV
⚠️ COLIN NEEDS OUR HELP! He is just 18 and has blood cancer. His only chance of survival is a blood stem cell donation, but there is no matching donor anywhere in the world. Please RT & help us find Colin his lifesaver 🙏🏽
Request a swab kit to register at https://t.co/PMmlwn5T7U
Fully vaccinated people account for just 1.2% of COVID deaths in England.
If you retweet one thing today, let this be it.
Please please get vaccinated.
Love,
NHS staff everywhere 💙
PS no hate please, we are literally trying to save your life.
Brexit: The EU and UK have reached a post-Brexit trade deal, ending months of disagreements over fishing rights and future business rules https://t.co/jBUPQTmBcR
Terminally ill cancer patient has been given the all-clear after becoming the first woman in Wales, to be given CAR-T treatment to fight cancer. https://t.co/6gpHkzFXj3
Very nice explanation of
How the Pfizer-BioNTech mRNA Vaccine Works?
Definitely worth a read for those wanting to understand better, and a share for those who'd like to educate their friends, family and colleagues better!
https://t.co/3kE37jC11B
Gene Editing Shows Promise in Sickle-Cell Disease. Drug development for sickle-cell disease, largely overlooked for decades. Data published in the New England Journal of Medicine report promising results from studies of experimental therapies (1/2).
https://t.co/A6BK2Zuo2Y
Best example is mRNA1273 LNP-encapsulated mRNA-based vaccine forCOVID19. Furthermore recently shown that light-sensitive LNP delivery offers precise gene editing with CRISPR-Cas9.Disruption of gene expression in-vivo using non-viral approaches opens new avenues for gene editing.
Numerous ways for gene editing for precision medicine, such as use of viral vectors. However, use of viral vectors has some serious concerns.
Lipid nanoparticles are clinically approved non-viral nucleic acid delivery systems.
https://t.co/BusM3cPVxr
This is our 3 years of hard work to produce Ultra-pure Off-The-Shelf CAR T Cells for CD19. So happy to see finally bench to clinic. This is just the beginning, I am more excited for the upcoming Off-The-Shelf CAR T cells for AML (CARAML) using Base Editing.https://t.co/TmznzqyRDw